AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 74 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $92,000 | -28.7% | 20,967 | 0.0% | 0.00% | -25.0% |
| Q2 2018 | $129,000 | -15.7% | 20,967 | 0.0% | 0.00% | -20.0% |
| Q1 2018 | $153,000 | -14.0% | 20,967 | -3.4% | 0.01% | -16.7% |
| Q4 2017 | $178,000 | -21.9% | 21,700 | 0.0% | 0.01% | -25.0% |
| Q3 2017 | $228,000 | -7.7% | 21,700 | -3.2% | 0.01% | 0.0% |
| Q2 2017 | $247,000 | -21.6% | 22,410 | -31.2% | 0.01% | -11.1% |
| Q1 2017 | $315,000 | – | 32,590 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 520,830 | $2,625,000 | 1.69% |
| COWEN AND COMPANY, LLC | 1,905,990 | $9,606,000 | 1.57% |
| Ghost Tree Capital, LLC | 825,000 | $4,158,000 | 1.20% |
| GENDELL JEFFREY L | 1,115,211 | $5,621,000 | 1.18% |
| Vivo Capital, LLC | 3,526,093 | $17,772,000 | 1.03% |
| ACUTA CAPITAL PARTNERS, LLC | 705,218 | $3,554,000 | 0.96% |
| RTW INVESTMENTS, LP | 5,366,705 | $27,048,000 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 2,840,669 | $14,317,000 | 0.50% |
| Avoro Capital Advisors LLC | 4,200,000 | $21,168,000 | 0.30% |
| HighVista Strategies LLC | 57,495 | $290,000 | 0.21% |